P. Eleftheriou

发表

Improved Myocardial T2* in Transfusion Dependent Anemias Receiving ICL670 (Deferasirox).

D. Pennell, M. Tanner, J. Porter, 2005 .

Beta-thalassemia: renal complications and mechanisms: a narrative review

P. Sarafidis, C. Demosthenous, E. Vlachaki, 2019, Hematology.

S110: ACUTE AND CHRONIC PAIN MANAGEMENT IN SICKLE CELL DISEASE: OUTCOMES OF AN ENGLISH NATIONAL AUDIT.

J. Howard, W. Atoyebi, P. Telfer, 2022, HemaSphere.

Protecting vulnerable patients with inherited anaemias from unnecessary death during the COVID‐19 pandemic

S. Lugthart, J. Howard, Farrukh T Shah, 2020, British journal of haematology.

MRI Evidence of Cardiac Iron Accumulation in Myelodysplasia and Unusual Anaemias.

J. Porter, P. Eleftheriou, Julie May Glanville, 2006 .

Classical infratentorial superficial siderosis of the central nervous system: pathophysiology, clinical features and management

S. Farmer, D. Werring, E. Chan, 2022, Practical Neurology.

Total Annual Economic Burden of Patients with Sickle Cell Disease in Steady State in Greece

M. Diamantidis, M. Papaioannou, D. Kouvelas, 2021, Hemoglobin.

Effect of automated red cell exchanges on oxygen saturation on-air, blood parameters and length of hospitalization in sickle cell disease patients with acute chest syndrome

J. Aneke, J. Porter, N. Huntley, 2016, Nigerian medical journal : journal of the Nigeria Medical Association.

Real-time national survey of COVID-19 in hemoglobinopathy and rare inherited anemia patients

F. Piel, S. Lugthart, R. Hollingsworth, 2020, Haematologica.

Neuropsychological and neuroimaging characteristics of classical superficial siderosis

S. Farmer, D. Werring, L. Cipolotti, 2021, Journal of Neurology.

Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis

S. Farmer, D. Werring, G. Banerjee, 2019, Journal of Neurology.

Symptomatic Erythrocytosis Due to Homozygosity for Hb Luton [HBA2: c.269A>T (or HBA1)] and α-Thalassemia: A Clinical Update

J. Porter, N. Huntley, Dana Warcel, 2016, Hemoglobin.

Genetic and Clinical Heterogeneity in Thirteen New Cases with Aceruloplasminemia. Atypical Anemia as a Clue for an Early Diagnosis

D. Girelli, N. Wood, A. Giorgetti, 2020, International journal of molecular sciences.

Impact of Compliance, Ferritin and LIC on Long-Term Trends in Myocardial T2* with Deferasirox

D. Pennell, M. Tanner, J. Porter, 2008 .

Treatment with IMR-687, a Highly Selective PDE9 Inhibitor, Increases HbF and Reduces VOCs in Adults with Sickle Cell Disease in a Long-Term, Phase 2a, Open-Label Extension Study

S. Lugthart, C. Barysauskas, K. Attie, 2021, Blood.

Recurrent acute lower-limb ischemia with multiple organ infarctions secondary to acute myeloid leukaemia M1.

G. Gravante, J. Overton, D. Frith, 2012, Annals of vascular surgery.

A comparative analysis across the globe: blood transfusion therapy in thalassaemia major

A. Eleftheriou, P. Eleftheriou, M. Demetriades, 2008 .